OMRON

OMRON’s healthcare division has achieved global leadership in blood pressure monitors with over 200 million units sold worldwide. Their products are widely used for cardiovascular risk reduction (“Zero Events” initiative), asthma care, and chronic pain relief. They also offer remote patient monitoring services to enable personalized healthcare.

No clinical trial results as would be typical for a pharma/biotech pipeline.

Recent activity includes the acquisition of Luscii Healthtech to expand digital healthcare capabilities.

Their business impact focuses on improved diagnosis/treatment of hypertension/cardiovascular diseases, early asthma intervention, and non-pharmacological pain therapy.

They regularly present at major medical congresses such as ESC Congress.